NASDAQ · Drug Manufacturers - Specialty & Generic

Universe Pharmaceuticals Inc (UPC) Stock

$4.15 -0.72% NASDAQ: UPC Healthcare

Valuation

MetricValue
Price$4.15
Market Cap$2.62M
P/E Ratio-1.30
P/B Ratio0.05
P/S Ratio0.16
EPS (TTM)$-1055.75
52-Week High$17.96
52-Week Low$2.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-3.48%
ROA-2.72%
ROCE-3.61%
Gross Margin-16.67%
Operating Margin-16.67%
Net Margin-10.95%
Debt/Equity0.17
Current Ratio4.15

Annual Financials (USD)

Metric20212022202320242025
Revenue$48.0M$40.0M$32.0M$23.0M$18.0M
Operating Profit$14.0M$-7.0M$-4.0M$-8.0M$-3.0M
Net Profit$11.0M$-9.0M$-6.0M$-9.0M$-4.0M
EPS$2147.18$-1475.02$-1040.53$-1436.12$-1055.75
Op Margin28.3%-17.5%-10.9%-34.8%-16.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$70.0M$60.0M$53.0M$68.0M$69.0M
Total Liabilities$11.0M$13.0M$14.0M$22.0M$13.0M
Cash$8.0M$6.0M$5.0M$29.0M$34.0M
Borrowings$4.0M$4.0M$5.0M$8.0M$9.0M

Latest News

Top Premarket Decliners MT Newswires · Jun 30, 2026 Top Midday Gainers MT Newswires · Jun 29, 2026 Top Premarket Gainers MT Newswires · Jun 29, 2026 UPC Stock Surges 288% After Hours — What’s Driving The Rally? Stocktwits · Jun 26, 2026 Universe Pharmaceuticals to Acquire Best Praise International MT Newswires · Jun 26, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-2.0M$-1.0M$1.0M$-10.0M$-5.0M
Investing Cash Flow$-41.0M$-4.0M$0$-1.0M$-1.0M
Financing Cash Flow$-3.0M$0$0$0$0
Net Cash Flow$-2.0M$-2.0M$0$24.0M$4.0M
Free Cash Flow$-16.0M$-1.0M$1.0M$-10.0M$-5.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA11.62
FCF Yield-435.92%
Quick Ratio3.75
Interest Coverage-9.11
Return 1Y31.72%
Return 3Y-99.63%
Return 5Y-99.95%

Ownership

Insiders Held11.38%
Institutions Held4.45%
Institutions Float Held5.02%
Institutional HolderSharesReport Date
UBS Group AG9462025-12-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $336.64 -1.11% 38.93 $4.94T 0.32%
MSFTMicrosoft Corporation $535.07 +2.38% 28.68 $3.97T 0.76%
GOOGLAlphabet Inc. $351.66 +0.97% 16.94 $4.26T 0.26%
AMZNAmazon.com, Inc. $262.43 +3.29% 19.82 $2.82T 0.00%
METAMeta Platforms, Inc. $718.67 -0.31% 27.93 $1.83T 0.28%

About Universe Pharmaceuticals Inc

Universe Pharmaceuticals Inc is led by CEO Gang Lai, employs 225 people, headquartered in CN, publicly traded since 2021.

Universe Pharmaceuticals Inc (UPC) stock trades at $4.15 with a market capitalization of $2.62M. The stock is valued at a price-to-earnings (P/E) ratio of -1.30, price-to-book of 0.05, price-to-sales of 0.16. Over the past 52 weeks the stock has ranged between $2.00 and $17.96, and currently trades 76.9% below its 52-week high.

On profitability, Universe Pharmaceuticals Inc generates a return on equity (ROE) of -3.48%, return on capital employed of -3.61%, an operating margin of -16.67%, a net profit margin of -10.95%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides